X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (159) 159
index medicus (134) 134
oncology (130) 130
male (89) 89
female (85) 85
middle aged (82) 82
aged (74) 74
cancer (67) 67
colorectal cancer (63) 63
adult (61) 61
chemotherapy (54) 54
colorectal neoplasms - pathology (51) 51
colorectal neoplasms - drug therapy (48) 48
treatment outcome (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
metastasis (40) 40
bevacizumab (34) 34
oxaliplatin (33) 33
prognosis (30) 30
care and treatment (29) 29
disease-free survival (29) 29
colorectal neoplasms - genetics (27) 27
research (27) 27
antineoplastic agents - therapeutic use (26) 26
neoplasm staging (26) 26
survival (25) 25
dendritic cells - immunology (24) 24
aged, 80 and over (23) 23
capecitabine (23) 23
fluorouracil - administration & dosage (23) 23
neoplasm metastasis (23) 23
combination chemotherapy (22) 22
immunotherapy (22) 22
melanoma - immunology (22) 22
analysis (20) 20
clinical trials (20) 20
colorectal neoplasms - mortality (20) 20
hematology, oncology and palliative medicine (20) 20
metastases (20) 20
phase-iii (20) 20
vaccination (20) 20
cetuximab (19) 19
fluorouracil (19) 19
organoplatinum compounds - administration & dosage (18) 18
surgery (18) 18
tumors (18) 18
liver neoplasms - secondary (17) 17
patients (17) 17
retrospective studies (17) 17
cancer therapies (16) 16
deoxycytidine - analogs & derivatives (16) 16
melanoma (16) 16
melanoma - therapy (16) 16
randomized controlled trials as topic (16) 16
1st-line treatment (15) 15
colorectal carcinoma (15) 15
drug administration schedule (15) 15
fluorouracil - analogs & derivatives (15) 15
immunology (15) 15
t-cells (15) 15
camptothecin - analogs & derivatives (14) 14
dendritic cells (14) 14
deoxycytidine - administration & dosage (14) 14
health aspects (14) 14
irinotecan (14) 14
medicine & public health (14) 14
melanoma - pathology (14) 14
patient outcomes (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
cancer vaccines - immunology (13) 13
colon-cancer (13) 13
liver metastases (13) 13
melanoma - drug therapy (13) 13
therapy (13) 13
antibodies, monoclonal - therapeutic use (12) 12
cancer patients (12) 12
clinical trials as topic (12) 12
colorectal neoplasms - therapy (12) 12
expression (12) 12
immune-responses (12) 12
in-vivo (12) 12
induction (12) 12
kaplan-meier estimate (12) 12
metastatic melanoma (12) 12
mutation (12) 12
survival analysis (12) 12
survival rate (12) 12
abridged index medicus (11) 11
drug therapy (11) 11
leucovorin (11) 11
maturation (11) 11
metastatic colorectal cancer (11) 11
skin neoplasms - drug therapy (11) 11
t-lymphocytes - immunology (11) 11
5-fluorouracil (10) 10
animals (10) 10
camptothecin - administration & dosage (10) 10
cancer vaccines - therapeutic use (10) 10
carcinoma (10) 10
chemotherapy, adjuvant (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (6) 6
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Institute for Christian Studies - Stacks (1) 1
Map & Data - Map Collection (1) 1
Thomas Fisher Rare Book - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 616 - 622
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 31, pp. 4706 - 4713
Panitumumab is a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody that improves progression-free survival (PFS) in... 
SURVIVAL | 1ST-LINE TREATMENT | CONTROLLED-TRIAL | SUPPORTIVE CARE | ONCOLOGY | CETUXIMAB PLUS IRINOTECAN | KRAS | OXALIPLATIN | FAILURE | CHEMOTHERAPY | Leucovorin - administration & dosage | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Chemotherapy, Adjuvant | Colorectal Neoplasms - metabolism | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Index Medicus
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue suppl_5, pp. v23 - v23
Journal Article
Journal of cellular and molecular medicine, ISSN 1582-1838, 2010, Volume 14, Issue 8, pp. 2122 - 2131
Journal Article